Skip to main content Back to Top

Perspectives on the Potential Impact of RFID Technology on Medication Safety

Broadcast Date: April 26, 2023


Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

In this episode, anesthesia and pharmacy leaders explore the potential impact of implementing radio frequency identification technology on patient and medication safety in care settings where sedation is administered. This ASHP Foundation podcast is part of an initiative supported by Fresenius Kabi.


Daniel NessDaniel Ness is the anesthesia medical director at Rady Children’s Hospital in San Diego. He has been at Rady since 2001. He was previously vice chief and chief of anesthesiology/critical care at Rady and was part of the team that tested and deployed an RFID enabled anesthesia med station throughout the institution. He continues to be the pharmacy liaison of the department of anesthesiology.

Pramod PatelPramod Patel is from Chicago, IL and earned his PharmD at Ohio Northern University in 2006. He graduated from SABA University School of Medicine in 2012 and completed an anesthesiology residency at Loyola University Medical Center in Chicago, IL in 2016. He is currently an assistant professor at the University of Chicago where he holds dual positions in the Department of Critical Care and Anesthesiology and the Geriatric and Palliative Medicine Department. He has interests in anesthetic pharmacology, medication safety and delivery and Palliative Medicine.

David AgueroDavid Aguero is the director of medication systems and informatics as well as the program director, PGY2 pharmacy informatics residency, at St. Jude Children’s Research Hospital in Memphis, Tennessee. At St. Jude, he is responsible for leadership of medication-use systems and supporting technologies including pharmacy informatics, pharmacy analytics, and pharmacy supply chain service lines.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.